Dietary Interventions for Treating Progressive Chronic Kidney Disease
The type and amount of ingested protein affects clinical outcomes such as protein-energy wasting, kidney function and even survival.
All articles by Csaba P. Kovesdy, MD
Cause-Specific Outcomes Associated with Hypovitaminosis D
The complex biological actions of vitamin D suggest its involvement in various pathologies. (This is the second of a two-part CME article.)
Vitamin D and Clinical Outcomes in Patients With and Without CKD: Part I
Research has shown that vitamin D deficiency has a role in the progressive loss of kidney function as well as increased mortality.
Managing ‘Burnt-Out’ Diabetes
In diabetic CKD patients, strict glycemic control may be harmful.
Phosphate-Lowering Therapy in CKD
This article is the first in a series that will discuss various aspects of hyperphosphatemia in patients with renal disease. Csaba P. Kovesdy, MD, chief of nephrology at the Salem VA Medical Center, in Salem, Va., is the series editor.
Obesity in CKD: Is It Friend or Foe?
In a seemingly paradoxical manner, observational studies examining outcomes in patients suffering from CKD have found significantly altered risk-factor patterns such that conventional mortality risk factors have been associated with better survival; this phenomenon was termed “reverse epidemiology” or “risk factor paradox.”
Hypertension: Still Public Enemy No. 1
Hypertension is the most important risk factor of mortality, accounting for about 12% of all deaths worldwide. Time and again, lowering BP has proved to be beneficial in randomized controlled trials.
How Phosphorus Affects CKD Patients
Phosphorus plays an important role in human life. It is an essential building block of the human body as a component of the bony skeleton, adenosine triphosphate, nucleic acids, phospholipid membranes, and blood and urinary buffers.
- Loading...
Loading...
Loading... 
Loading...